Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
COVID-19 vaccine immunogenicity and safety surrounding fourth and subsequent vaccine doses in patients with hematologic malignancies.
Bhella S, Wilkin AM, Hueniken K, Vijenthira A, Sebag M, Wang P, Hicks LK, Hay AE, Assouline S, Fraser G, Balitsky A, Mangel J, Owen C, Reiman A, Sehn L, Sutherland H, Zhang T, Arnold C, Leite T, McCarthy E, Cooper C, Langlois MA, Arianne Buchan C; VIP Study Investigators. Bhella S, et al. Among authors: mangel j. Vaccine. 2024 Oct 24;42(24):126074. doi: 10.1016/j.vaccine.2024.06.041. Epub 2024 Jun 28. Vaccine. 2024. PMID: 38944577 Free article.
Treatment outcomes for older patients with relapsed/refractory aggressive lymphoma receiving salvage chemotherapy and autologous stem cell transplantation are similar to younger patients: a subgroup analysis from the phase III CCTG LY.12 trial.
Davison K, Chen BE, Kukreti V, Couban S, Benger A, Berinstein NL, Kaizer L, Desjardins P, Mangel J, Zhu L, Djurfeldt MS, Hay AE, Shepherd LE, Crump M. Davison K, et al. Among authors: mangel j. Ann Oncol. 2017 Mar 1;28(3):622-627. doi: 10.1093/annonc/mdw653. Ann Oncol. 2017. PMID: 27993811 Free article. Clinical Trial.
Serologic Response to Vaccine for COVID-19 in Patients with Hematologic Malignancy: A Prospective Cohort Study.
Hillyer A, Quint A, Ghassemian A, Joh-Carnella N, Knauer MJ, Dawd D, Lazo-Langner A, Mangel J, Lam S, Abdoh H, Xenocostas A, Deotare U, Saini L, Foster C, Louzada M, Ho J, Chin-Yee I, Phua CW. Hillyer A, et al. Among authors: mangel j. Clin Lymphoma Myeloma Leuk. 2024 May;24(5):305-315. doi: 10.1016/j.clml.2024.01.004. Epub 2024 Jan 18. Clin Lymphoma Myeloma Leuk. 2024. PMID: 38336492 Free article.
Rituximab purging and maintenance combined with auto-SCT: long-term molecular remissions and prolonged hypogammaglobulinemia in relapsed follicular lymphoma.
Hicks LK, Woods A, Buckstein R, Mangel J, Pennell N, Zhang L, Imrie K, Spaner D, Cheung MC, Boudreau A, Reis M, Crump M, Berinstein NL. Hicks LK, et al. Among authors: mangel j. Bone Marrow Transplant. 2009 May;43(9):701-8. doi: 10.1038/bmt.2008.382. Epub 2008 Nov 24. Bone Marrow Transplant. 2009. PMID: 19029963 Clinical Trial.
Intensity of survivin expression linked to features of aggressive relapsed/refractory diffuse large B-cell lymphoma.
Usta S, Misura A, Rashedi I, Amitai I, Roos K, Jiang Y, Mangoff K, Klein G, Forward N, Stewart D, Mangel J, Tomlinson G, Tsui H, Berinstein NL. Usta S, et al. Among authors: mangel j. Leuk Lymphoma. 2025 Jan;66(1):84-94. doi: 10.1080/10428194.2024.2403668. Epub 2024 Sep 27. Leuk Lymphoma. 2025. PMID: 39328061 Free article. Clinical Trial.
97 results